LY-2608204 is an activator of glucokinase (GK) with an EC50 value of 42 nM. LY2608204 decreases plasma glucose in a dose-dependent manner at both fasted and postprandial glucose levels. In 2010, LY-2608204 was entered clinical trials in Patients With Type 2 Diabetes.
MedKoo Cat#: 522676
Name: LY-2608204
CAS#: 1234703-40-2 (free base)
Chemical Formula: C28H37N3O3S3
Exact Mass: 559.1997
Molecular Weight: 559.80
Elemental Analysis: C, 60.08; H, 6.66; N, 7.51; O, 8.57; S, 17.18
Solvent | mg/mL | mM | |
---|---|---|---|
Solubility | |||
DMF | 33.0 | 58.95 | |
DMF:PBS (pH 7.2) (1:2) | 0.3 | 0.59 | |
DMSO | 79.0 | 141.12 | |
Ethanol | 35.0 | 62.52 |
The following data is based on the product molecular weight 559.80 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |